| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 11/30/2005 | CN1229386C Novel human protein with function for suppressing cancer and coding sequence thereof |
| 11/30/2005 | CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof |
| 11/30/2005 | CN1229114C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 11/29/2005 | US6969763 Molecular interaction sites of interleukin-2 RNA and methods of modulating the same |
| 11/29/2005 | US6969762 DNA sequence clone |
| 11/29/2005 | US6969761 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 11/29/2005 | US6969760 Jak kinases and regulation of cytokine signal transduction |
| 11/29/2005 | US6969704 contacting the cells of the tissue ex vivo with a nucleic acid containing the polynucleotide sequence 5'-CTTGGCCGCTGCCAT-3' prior to the tissue's transplantation into a subject, for reducing damage to an ischemic tissue |
| 11/29/2005 | US6969603 Method for isolating DNA |
| 11/29/2005 | US6969599 Nucleic acids encoding tumor necrosis factor receptor TR10 |
| 11/29/2005 | US6969596 Polynucleotide encoding a human receptor tyrosine kinase |
| 11/29/2005 | US6969589 Screening nucleic acid sample and detecting nucleotide sequences polymorphisms; obtain mammalian nucleic acid sequence, determine sequence, compare to control, detect adjustment, expose drug, monitor and evaluate response |
| 11/29/2005 | CA2318160C Asymmetric cyanine dye quenchers |
| 11/29/2005 | CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e |
| 11/24/2005 | WO2005111240A2 Field-switch sequencing |
| 11/24/2005 | WO2005111235A2 Methods for detecting chromosome aberrations |
| 11/24/2005 | WO2005111217A2 Nicotiana nucleic acid molecules and uses thereof |
| 11/24/2005 | WO2005111061A1 Method for producing chemical microarrays |
| 11/24/2005 | WO2005111059A2 Process for the reduction of endotoxins |
| 11/24/2005 | WO2005111057A2 Immunostimulatory nucleic acids for inducing il-10 responses |
| 11/24/2005 | WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | WO2005080431A3 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 11/24/2005 | WO2005073383A3 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 11/24/2005 | WO2005065239A3 Novel recombinant proteins with n-terminal free thiol |
| 11/24/2005 | WO2005047511A3 Bacterial expression of protease inhibitors and variants thereof |
| 11/24/2005 | WO2005046710A3 Tgf-beta binding and supported peptides |
| 11/24/2005 | WO2005046709A3 Tgf - beta binding and supported peptides |
| 11/24/2005 | WO2005033132A3 Igf binding proteins |
| 11/24/2005 | WO2004092391A3 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms |
| 11/24/2005 | WO2004042346A3 Methods and compositions for diagnosing and monitoring transplant rejection |
| 11/24/2005 | US20050262589 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 11/24/2005 | US20050262587 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 11/24/2005 | US20050262586 Low temperature responsive nucleotide sequences and uses thereof |
| 11/24/2005 | US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 11/24/2005 | US20050261487 Dna molecules encoding ligand-gated ion channels from drosophila melanogaster |
| 11/24/2005 | US20050261486 Compositions and methods for binding agglomeration proteins |
| 11/24/2005 | US20050261485 Method of producing antisense oligonucleotide |
| 11/24/2005 | US20050261477 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 11/24/2005 | US20050261474 Method of support-based chemical synthesis |
| 11/24/2005 | US20050261235 2' ,5' -Oligoadenylate analogs |
| 11/24/2005 | US20050261234 GFAP-based gene therapy for treatment of retinal diseases |
| 11/24/2005 | US20050261233 Modulation of glucose-6-phosphatase translocase expression |
| 11/24/2005 | US20050261228 Polynucleotide; diagnosis, therapy of Crohn's disese, encephalomyelitis, antitumor agents; modulate interleukins |
| 11/24/2005 | US20050261226 Methods and compositions for the treatment of cancer with oligonucleotides directed against Egr-1 |
| 11/24/2005 | US20050261218 Oligomeric compounds and compositions for use in modulation small non-coding RNAs |
| 11/24/2005 | US20050261217 Modulation of pumilio 1 expression |
| 11/24/2005 | US20050261216 Modulation of Nanos 1 expression |
| 11/24/2005 | US20050261192 Novel polypeptide and its DNA |
| 11/24/2005 | US20050261170 Folate conjugates and complexes |
| 11/24/2005 | US20050260758 High efficiency peptide production in plant cells |
| 11/24/2005 | US20050260746 Transgenic pig containing heat shock protein 70 transgene |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260728 Polypeptides; genetic engineering; acinetobacter culture product |
| 11/24/2005 | US20050260726 Novel human protease inhibitor and polynucleotides encoding the same |
| 11/24/2005 | US20050260716 Non-immunoglobulin polypeptide, linker and dimerizing domain; cell-surface receptors; signal transduction |
| 11/24/2005 | US20050260715 Efficient methods for producing antimicrobial cationic peptides in host cells |
| 11/24/2005 | US20050260714 Novel compounds |
| 11/24/2005 | US20050260712 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |
| 11/24/2005 | US20050260711 Modulating pH-sensitive binding using non-natural amino acids |
| 11/24/2005 | US20050260709 Lipin1 function |
| 11/24/2005 | US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/24/2005 | US20050260675 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 11/24/2005 | US20050260674 Specific polypeptides, useful as nematocides |
| 11/24/2005 | US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals |
| 11/24/2005 | US20050260667 determining the predisposition of individuals to schizophrenia, bipolar disorder and mental disorders; drug screening; reduced side effects |
| 11/24/2005 | US20050260662 Genotyping of multiple loci with PCR for different loci amplification at different temperatures |
| 11/24/2005 | US20050260659 Compositions and methods for breast cancer prognosis |
| 11/24/2005 | US20050260656 Rapid analysis of variations in a genome |
| 11/24/2005 | US20050260650 Alternatively spliced isoforms of interleukin-4 receptor subunit alpha (IL-4Ralpha) |
| 11/24/2005 | US20050260643 Cancer specific promoters |
| 11/24/2005 | US20050260642 CNGH0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 11/24/2005 | US20050260637 Drug screening |
| 11/24/2005 | US20050260633 Primers for use in detecting beta-lactamases |
| 11/24/2005 | US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260629 Differential drug sensitivity |
| 11/24/2005 | US20050260625 Process and system for crosslinking polynucleotide molecules |
| 11/24/2005 | US20050260624 Novel nucleic acid complexes and detection thereof |
| 11/24/2005 | US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260621 Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof |
| 11/24/2005 | US20050260620 Hearing loss, deafness, tinnitus, motion and balance disorders, cancer and proliferative diseases |
| 11/24/2005 | US20050260617 Oligo-or polynucleotides |
| 11/24/2005 | US20050260614 Methods for real-time single molecule sequence determination |
| 11/24/2005 | US20050260604 Antigens derived from the core protein of the human mammary epithelial mucin |
| 11/24/2005 | US20050260603 Compositions for inferring bovine traits |
| 11/24/2005 | US20050260600 Amino radicals; magnetic bodies, metals, plastic and glass beads or gel; increased recovery ratio |
| 11/24/2005 | US20050260598 Novel clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said protein |
| 11/24/2005 | US20050260594 Method for detection of 5T4 RNA in plasma or serum |
| 11/24/2005 | US20050260593 Fluorescent labeling reagents with multiple donors and acceptors |
| 11/24/2005 | US20050260584 Nucleic acids for the identification of fungi and methods for using the same |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260578 Antisense modulation of cellular apoptosis susceptibity gene expression |
| 11/24/2005 | US20050260576 Recombinantly expressed and isolated human SCN1A polypeptide and a modified human SCN1A nucleic acid that encodes it; producing an antibody that specifically binds a sodium channel; detecting and/or identifying a sodium channel polypeptide; anticonvulsants, neuroprotective agents and analgesics |
| 11/24/2005 | US20050260574 Combinatorial probes and uses therefor |
| 11/24/2005 | US20050260570 Sequencing by proxy |
| 11/24/2005 | US20050260219 Carboxypeptidases B from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260194 Immunoglobulin chimeric monomer-dimer hybrids |
| 11/24/2005 | US20050260186 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms |
| 11/24/2005 | US20050260131 Pharmaceuticals for enhanced delivery to disease targets |